This is an aggregated industry headline. Read the full story at BioPharma Dive →
AstraZeneca, GSK intensify China ties with Sino Biopharm deals
The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.
By BioPharma Dive
· Jul 8, 2026
· via BioPharma Dive
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineBioPharma Dive
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Allergan Aesthetics on Tuesday welcomed Girls Inc. participants to a panel and tour at its Allergan Medical In…
The WeekFierceBiotech ↗
The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, F…
The WeekBriefing
The newly approved Dexcom Stelo continuous glucose monitor opens access beyond diabetes management, prompting …